Literature DB >> 33513906

Nitroreductase Activites in Giardia lamblia: ORF 17150 Encodes a Quinone Reductase with Nitroreductase Activity.

Joachim Müller1, Manfred Heller2, Anne-Christine Uldry2, Sophie Braga2, Norbert Müller1.   

Abstract

The intestinal diplomonadid Giardia lamblia is a causative agent of persistent diarrhea. Current treatments are based on nitro drugs, especially metronidazole. Nitro compounds are activated by reduction, yielding toxic intermediates. The enzymatic systems responsible for this activation are not completely understood. By fractionating cell free crude extracts by size exclusion chromatography followed by mass spectrometry, enzymes with nitroreductase (NR) activities are identified. The protein encoded by ORF 17150 found in two pools with NR activities is overexpressed and characterized. In pools of fractions with main NR activities, previously-known NRs are identified, as well as a previously uncharacterized protein encoded by ORF 17150. Recombinant protein 17150 is a flavoprotein with NADPH-dependent quinone reductase and NR activities. Besides a set of previously identified NRs, we have identified a novel enzyme with NR activity.

Entities:  

Keywords:  anaerobic metabolism; drug susceptibility; functional assays; mass spectrometry; protein chromatography

Year:  2021        PMID: 33513906     DOI: 10.3390/pathogens10020129

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  2 in total

1.  Characterization of Metronidazole-Resistant Giardia intestinalis Lines by Comparative Transcriptomics and Proteomics.

Authors:  Sascha Krakovka; Ulf Ribacke; Yukiko Miyamoto; Lars Eckmann; Staffan Svärd
Journal:  Front Microbiol       Date:  2022-02-10       Impact factor: 6.064

2.  Common Molecular Targets of a Quinolone Based Bumped Kinase Inhibitor in Neospora caninum and Danio rerio.

Authors:  Joachim Müller; Nicoleta Anghel; Dennis Imhof; Kai Hänggeli; Anne-Christine Uldry; Sophie Braga-Lagache; Manfred Heller; Kayode K Ojo; Luis-Miguel Ortega-Mora; Wesley C Van Voorhis; Andrew Hemphill
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.